Ceftolozane
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09050 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 38 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gonococcal urethritis | KG + DL |
| 2 | Ureaplasma urethritis | KG + DL |
| 3 | uterine inflammatory disease | KG + DL |
| 4 | xanthogranulomatous pyelonephritis | KG + DL |
| 5 | hyperamylasemia | KG + DL |
| 6 | polyclonal hyperviscosity syndrome | KG + DL |
| 7 | urogenital tuberculosis | KG + DL |
| 8 | congenital analbuminemia | KG + DL |
| 9 | blood group incompatibility | KG + DL |
| 10 | premalignant hematological system disease | KG + DL |
| 11 | monoclonal gammopathy | KG + DL |
| 12 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 13 | congenital hematological disorder | KG + DL |
| 14 | septicemic plague | KG + DL |
| 15 | epiglottitis | KG + DL |
| 16 | hematopoietic and lymphoid system neoplasm | KG + DL |
| 17 | pyelitis | KG + DL |
| 18 | laryngitis | KG + DL |
| 19 | abdominal tuberculosis | KG + DL |
| 20 | bubonic plague | KG + DL |
| 21 | IgG4-related mesenteritis | KG + DL |
| 22 | eosinophilic angiocentric fibrosis | KG + DL |
| 23 | IgG4-related aortitis | KG + DL |
| 24 | IgG4-related mediastinitis | KG + DL |
| 25 | post-infectious neuralgia | KG + DL |
| 26 | hepatitis C induced liver cirrhosis | KG + DL |
| 27 | primitive portal vein thrombosis | KG + DL |
| 28 | hepatoportal sclerosis | KG + DL |
| 29 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 30 | idiopathic copper-associated cirrhosis | KG + DL |
| 31 | hepatopulmonary syndrome | KG + DL |
| 32 | sequela of COVID-19 | KG + DL |
| 33 | IgG4-related pachymeningitis | KG + DL |
| 34 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 35 | herpes zoster | KG + DL |
| 36 | IgG4-related hepatopathy | KG + DL |
| 37 | Peptostreptococcus infectious disease | KG + DL |
| 38 | L-ferritin deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.